Pain Management Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Fibromyalgia: Changes Since 1990

Since the release of criteria for the diagnosis of fibromyalgia in 1990, much more is known about this syndrome.

Short-Term Opioid Use for LBP

There is evidence of short-term efficacy of opioids for treatment of chronic low back pain compared with placebo, according to a new study.

NSAIDs, Anticoagulants, Bleeding Risk

Use of an NSAID or aspirin in patients with venous thromboembolism receiving anticoagulant therapy is tied to increased risk of bleeding.

FDA Approves Opioid Overdose Reversal

The FDA has approved Evzio (naloxone HCl injection; Kaléo, Inc.) for the emergency treatment of known or suspected opioid overdose.

Can Pain Relievers Fight "Superbugs"?

Common NSAIDs may help to prevent the rise of antibiotic-resistant bacteria ("superbugs") by providing an alternative treatment for infections.

Brain Scans for Headaches Unnecessary

Research has found that routine headache neuroimaging is frequently ordered by doctors for patients suffering from headaches.

Chart: Narcotic Analgesics

Review this updated chart on narcotic analgesics for quick information when you need it.

New Drug Product: Zubsolv

Maintenance treatment of opioid dependence, as part of a complete treatment plan to include counseling and psychosocial support.

Videos

News

Marcaine Recalled Due to Visible Particulates

Hospira announced a voluntary nationwide recall of one lot of 0.25% Marcaine (bupivacaine HCl) injection, single-dose 10mL vials due to discolored solution with visible particles embedded in the glass as well as the presence of discolored solution.

FDA Considers First-of-Kind Combo Pain Medication

The FDA Anesthetic and Analgesic Drug Products Advisory Committee will be meeting to evaluate QRxPharma's revised New Drug Application (NDA) for Moxduo (morphine sulfate and oxycodone hydrochloride) for the management of moderate to severe acute pain.

Particulate Found in Lidocaine HCl Inj

Hospira has initiated a voluntary recall of one lot of Lidocaine HCl injection 1%, 10mg/mL, single-dose 30mL vials due to an orange and black particulate found within the solution and embedded within the glass vial.

Featured courses from mycme

Pain Management Workshop (Pharmacology Credit)External web site

This program will discuss the causes of chronic pain as well as pharmacological options for ...

CE 3.00 Credits

Debridement Training: Principles & PracticeExternal web site

This course offers practicing physicians, mid-level practitioners, nurses and other allied health professionals a comprehensive ...

CME|CE 4.00 Credits

The Safe Use of Opioids in the Treatment of PainExternal web site

To minimize the risk of abuse and addiction, evidence-based prescribing practices must be used when ...

CME|CE 0.50 Credits
More myCME courses »

Sign Up for Free e-newsletters